Skip to main content
Premium Trial:

Request an Annual Quote

VWR to Market Products, Services Made by Clinical Data’s Cogenics Business

NEW YORK (GenomeWeb News) — VWR will market products in Clinical Data’s Cogenics division, including its DNA sequencing services, to European companies and academic centers, Clinical Data said today.
 
Cogenics sells products and services once owned by Lark Technologies and Genome Express.
 
Financial terms of the deal were not released.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.